220 related articles for article (PubMed ID: 35833131)
21. Single-cell analysis reveals immune modulation and metabolic switch in tumor-draining lymph nodes.
Li YL; Chen CH; Chen JY; Lai YS; Wang SC; Jiang SS; Hung WC
Oncoimmunology; 2020 Oct; 9(1):1830513. PubMed ID: 33117603
[TBL] [Abstract][Full Text] [Related]
22. Detrimental Effect of Type I IFNs During Acute Lung Infection With
Pylaeva E; Bordbari S; Spyra I; Decker AS; Häussler S; Vybornov V; Lang S; Jablonska J
Front Immunol; 2019; 10():2190. PubMed ID: 31572395
[No Abstract] [Full Text] [Related]
23. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
[TBL] [Abstract][Full Text] [Related]
24. Type I interferon supports γδ T-cell homeostasis and immunity through direct and indirect receptor signaling in mice.
Agerholm R; Kadekar D; Rizk J; Bekiaris V
Eur J Immunol; 2021 Dec; 51(12):3186-3193. PubMed ID: 34624928
[TBL] [Abstract][Full Text] [Related]
25. Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling.
Winkelmann ER; Widman DG; Xia J; Ishikawa T; Miller-Kittrell M; Nelson MH; Bourne N; Scholle F; Mason PW; Milligan GN
Vaccine; 2012 Feb; 30(8):1465-75. PubMed ID: 22226862
[TBL] [Abstract][Full Text] [Related]
26. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
27. Neutrophils in primary gastric tumors are correlated with neutrophil infiltration in tumor-draining lymph nodes and the systemic inflammatory response.
Hiramatsu S; Tanaka H; Nishimura J; Sakimura C; Tamura T; Toyokawa T; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Immunol; 2018 Apr; 19(1):13. PubMed ID: 29661142
[TBL] [Abstract][Full Text] [Related]
28. Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections.
Majer O; Bourgeois C; Zwolanek F; Lassnig C; Kerjaschki D; Mack M; Müller M; Kuchler K
PLoS Pathog; 2012; 8(7):e1002811. PubMed ID: 22911155
[TBL] [Abstract][Full Text] [Related]
29. Neutrophil Maturation and Survival Is Controlled by IFN-Dependent Regulation of NAMPT Signaling.
Siakaeva E; Pylaeva E; Spyra I; Bordbari S; Höing B; Kürten C; Lang S; Jablonska J
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717318
[TBL] [Abstract][Full Text] [Related]
30. Phenotypically distinct neutrophils patrol uninfected human and mouse lymph nodes.
Lok LSC; Dennison TW; Mahbubani KM; Saeb-Parsy K; Chilvers ER; Clatworthy MR
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19083-19089. PubMed ID: 31484769
[TBL] [Abstract][Full Text] [Related]
31. Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection.
Goritzka M; Durant LR; Pereira C; Salek-Ardakani S; Openshaw PJ; Johansson C
J Virol; 2014 Jun; 88(11):6128-36. PubMed ID: 24648449
[TBL] [Abstract][Full Text] [Related]
32. Type I interferon is selectively required by dendritic cells for immune rejection of tumors.
Diamond MS; Kinder M; Matsushita H; Mashayekhi M; Dunn GP; Archambault JM; Lee H; Arthur CD; White JM; Kalinke U; Murphy KM; Schreiber RD
J Exp Med; 2011 Sep; 208(10):1989-2003. PubMed ID: 21930769
[TBL] [Abstract][Full Text] [Related]
33. Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principles.
Koukourakis MI; Giatromanolaki A
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188704. PubMed ID: 35227831
[TBL] [Abstract][Full Text] [Related]
34. Type I IFN signaling in T regulatory cells modulates chemokine production and myeloid derived suppressor cells trafficking during EAE.
Tanwar S; Oguz C; Metidji A; Dahlstrom E; Barbian K; Kanakabandi K; Sykora L; Shevach EM
J Autoimmun; 2020 Dec; 115():102525. PubMed ID: 32709481
[TBL] [Abstract][Full Text] [Related]
35. IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections.
Shepardson KM; Larson K; Johns LL; Stanek K; Cho H; Wellham J; Henderson H; Rynda-Apple A
Front Immunol; 2018; 9():2589. PubMed ID: 30473701
[TBL] [Abstract][Full Text] [Related]
36. Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway.
Alicea-Torres K; Sanseviero E; Gui J; Chen J; Veglia F; Yu Q; Donthireddy L; Kossenkov A; Lin C; Fu S; Mulligan C; Nam B; Masters G; Denstman F; Bennett J; Hockstein N; Rynda-Apple A; Nefedova Y; Fuchs SY; Gabrilovich DI
Nat Commun; 2021 Mar; 12(1):1717. PubMed ID: 33741967
[TBL] [Abstract][Full Text] [Related]
37. Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1.
Xia C; Vijayan M; Pritzl CJ; Fuchs SY; McDermott AB; Hahm B
J Virol; 2015 Dec; 90(5):2403-17. PubMed ID: 26676772
[TBL] [Abstract][Full Text] [Related]
38. Rectal cancer induces a regulatory lymphocytic phenotype in the tumor-draining lymph nodes to promote cancer cell installation.
Giatromanolaki A; Koukourakis IM; Chatzipantelis P; Kouroupi M; Balaska K; Koukourakis MI
Immunol Res; 2020 Dec; 68(6):363-372. PubMed ID: 33150567
[TBL] [Abstract][Full Text] [Related]
39. Critical role for constitutive type I interferon signaling in the prevention of cellular transformation.
Chen HM; Tanaka N; Mitani Y; Oda E; Nozawa H; Chen JZ; Yanai H; Negishi H; Choi MK; Iwasaki T; Yamamoto H; Taniguchi T; Takaoka A
Cancer Sci; 2009 Mar; 100(3):449-56. PubMed ID: 19076978
[TBL] [Abstract][Full Text] [Related]
40. Intratumoral injection of interferon-α and systemic delivery of agonist anti-CD137 monoclonal antibodies synergize for immunotherapy.
Dubrot J; Palazón A; Alfaro C; Azpilikueta A; Ochoa MC; Rouzaut A; Martinez-Forero I; Teijeira A; Berraondo P; Le Bon A; Hervás-Stubbs S; Melero I
Int J Cancer; 2011 Jan; 128(1):105-18. PubMed ID: 20309938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
